LifeMD Inc expected to post a loss of 14 cents a share - Earnings Preview
LifeMD Inc LFMD.O is expected to show a fall in quarterly revenue when it reports results on November 12 for the period ending September 30 2026
The New York City-based company is expected to report a 18.8% decrease in revenue to $48.885 million from $60.17 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.The company's guidance on August 5 2026, for the period ended September 30, was for revenue between $48.00 million and $51.00 million.
LSEG's mean analyst estimate for LifeMD Inc is for a loss of 14 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for LifeMD Inc is $7.50, about 258% above its last closing price of $2.10
The company's guidance on August 5 2026 for the period ended September 30 was for Earnings before Interest, Taxes, Depreciation and Amortization of between 48 million and 2 million (USD).
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2026 | -0.16 | -0.15 | -0.16 | Missed | -9.8 |
Mar. 31 2026 | -0.23 | -0.22 | -0.20 | Beat | 9.9 |
Dec. 31 2025 | -0.06 | -0.03 | -0.04 | Missed | -20 |
Sep. 30 2025 | -0.05 | -0.05 | -0.07 | Missed | -50 |
Jun. 30 2025 | 0.01 | -0.01 | -0.06 | Missed | -650 |
Mar. 31 2025 | -0.06 | -0.05 | 0.01 | Beat | 118.9 |
Dec. 31 2024 | -0.07 | -0.05 | -0.02 | Beat | 61.1 |
Sep. 30 2024 | -0.12 | -0.12 | -0.14 | Missed | -18 |
This summary was machine generated November 10 at 21:04 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)